Abstract P5-06-12: Validation of residual proliferative cancer burden (RPCB) as a predictor of long-term outcome following neoadjuvant chemotherapy in hormone-receptor positive/HER2 negative breast cancer patients

Mapping Intimacies ◽

10.1158/1538-7445.sabcs19-p5-06-12 ◽

2020 ◽

Author(s):

Federica Miglietta ◽

Vassilena Tsvetkova ◽

Maria Vittoria Dieci ◽

Gaia Griguolo ◽

Grazia Vernaci ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Hormone Receptor ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome ◽

Cancer Burden ◽

Hormone Receptor Positive

Download Full-text

Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2020-0201 ◽

2020 ◽

Vol 25 (9) ◽

Cited By ~ 1

Author(s):

Federica Miglietta ◽

Maria Vittoria Dieci ◽

Vassilena Tsvetkova ◽

Gaia Griguolo ◽

Grazia Vernaci ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Hormone Receptor ◽

Term Outcome ◽

Long Term Outcome ◽

Cancer Burden ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy

European Journal of Cancer ◽

10.1016/j.ejca.2021.06.018 ◽

2021 ◽

Vol 155 ◽

pp. 28-37

Author(s):

Conny Vrieling ◽

Samson Y. Assele ◽

Lotte Moser ◽

Nicolas Sauvé ◽

Saskia Litière ◽

...

Keyword(s):

Breast Cancer ◽

Local Recurrence ◽

Cancer Patients ◽

Breast Conserving Therapy ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome ◽

Isolated Local Recurrence ◽

The Impact

Download Full-text

Long-Term Outcome of Breast Cancer Patients with One to Two Nodes Involved - Application of Nodal Ratio

The Breast Journal ◽

10.1111/tbj.12010 ◽

2012 ◽

Vol 18 (6) ◽

pp. 542-548 ◽

Cited By ~ 1

Author(s):

Patricia Tai ◽

Kurian Joseph ◽

Ali El-Gayed ◽

Edward Yu

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome ◽

Nodal Ratio

Download Full-text

Abstract P4-15-05: Long-term outcome of breast cancer patients treated with radiofrequency ablation

10.1158/0008-5472.sabcs12-p4-15-05 ◽

2012 ◽

Author(s):

M Earashi ◽

M Noguchi ◽

A Motoyoshi ◽

H Komiya ◽

H Fujii

Keyword(s):

Breast Cancer ◽

Radiofrequency Ablation ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

Long-Term Outcome of Breast Cancer Patients with One to Two Nodes Involved – Application of Nodal Ratio

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2013.04.022 ◽

2013 ◽

Vol 24 (2) ◽

pp. 155-156

Author(s):

D. Peterson ◽

P.T. Truong

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome ◽

Nodal Ratio

Download Full-text

Long-term Outcome of HER2-positive Early Breast Cancer Patients in the Trastuzumab Era: a Single Centre Experience

Clinical Oncology ◽

10.1016/j.clon.2017.01.012 ◽

2017 ◽

Vol 29 (6) ◽

pp. e97

Author(s):

P. Aravind ◽

C. Jingree ◽

F. Castell ◽

A. Rigg

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Single Centre ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome ◽

Single Centre Experience

Download Full-text

Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab

The Breast ◽

10.1016/j.breast.2015.09.008 ◽

2015 ◽

Vol 24 (6) ◽

pp. 751-757 ◽

Cited By ~ 15

Author(s):

B. Yeo ◽

K. Kotsori ◽

K. Mohammed ◽

G. Walsh ◽

I.E. Smith

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapy

Molecular and Clinical Oncology ◽

10.3892/mco.2014.365 ◽

2014 ◽

Vol 2 (6) ◽

pp. 997-1002 ◽

Cited By ~ 2

Author(s):

JIA YI WU ◽

WEI GUO CHEN ◽

XIAO SONG CHEN ◽

OU HUANG ◽

JIAN RONG HE ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Hormone Receptor Status ◽

Breast Cancer Patients ◽

Long Term Outcomes ◽

Negative Change

Download Full-text

Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status

European Journal of Cancer ◽

10.1016/j.ejca.2017.01.008 ◽

2017 ◽

Vol 75 ◽

pp. 323-332 ◽

Cited By ~ 10

Author(s):

Sylvie Giacchetti ◽

Anne-Sophie Hamy ◽

Suzette Delaloge ◽

Etienne Brain ◽

Frédérique Berger ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Her2 Status ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

First Report of Long-Term Responders to First-Line Bevacizumab (BEV) Combined With Chemotherapy in Two Independent Cohorts of HER2-Neg Metastatic Breast Cancer Patients (PTS) With Hormone Receptor –Positive (HR+) and Triple-Negative (TN) Tumors

Annals of Oncology ◽

10.1016/s0923-7534(20)32917-3 ◽

2012 ◽

Vol 23 ◽

pp. ix128

Author(s):

M. Saghatchian ◽

C. Levy ◽

C.B. Villanueva ◽

J. Fleury ◽

V. Diéras ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Triple Negative ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Hormone Receptor Positive

Download Full-text